Quantcast

Latest Gene therapy Stories

2014-06-18 23:10:57

OMICS Group International is pleased to announce the 3rd International Conference and Exhibition on Cell & Gene Therapy to be held during October 27-29, 2014 in Las Vegas, USA. Cell Therapy conference takes the opportunity to explore the cell and magnify the therapeutization potential on the application grounds of genetic knowhow. Henderson, NV (PRWEB) June 18, 2014 Cell Therapy-2014 is a remarkable event which brings together research eminent from the expertise of cell and gene...

2014-06-18 08:29:50

AMSTERDAM and PETACH TIKVA, Israel, June 18, 2014 /PRNewswire/ -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, and Medison Pharma Ltd., Israel's leading international healthcare marketing group, today announced an exclusive distribution agreement under which Medison will market Glybera(R), uniQure's gene therapy product for the treatment of lipoprotein lipase deficiency (LPLD), in Israel and the Palestinian Authority. Medison will also be responsible for...

2014-06-18 04:21:16

Unique Immuno-Oncolytic Therapy Gets Closer to a More Effective, Safer Cancer Treatment and Potential Cure CLEVELAND, June 18, 2014 /PRNewswire-USNewswire/ --­­ Western Oncolytics Ltd., a biotech company specializing in immuno-oncolytic cancer therapies, has closed $275,000 in seed funding. The proceeds are planned to set a path toward clinical trials and execute initial manufacturing for its novel virus-based cancer therapy, which delivers genes to guide the immune system to kill...

2014-06-16 08:29:08

Company will draw on leaders' expertise in rare diseases, R&D and commercialization as it moves to complete development of its lead program in inherited blindness PHILADELPHIA, June 16, 2014 /PRNewswire/ -- Spark Therapeutics, a late-stage gene therapy company developing treatments for a wide range of rare, debilitating diseases, announced today the appointments of Lars Ekman, former president of research and development at Elan, and Vin Milano, former president and CEO of...

2014-06-12 12:26:31

Lack of Disease-Modifying Therapies is Expected to Remain a Critical Unmet Need and Provides Ample Opportunity for Developers, According to Findings from Decision Resources Group BURLINGTON, Mass., June 12, 2014 /PRNewswire/ -- Decision Resources Group finds that three therapies, Teva's Huntexil, Auspex's SD-809 and Raptor's Procysbi, will likely receive regulatory approval for Huntington's disease (HD) in the United States and the EU5 markets (Germany, France, Italy, Spain and United...

2014-06-12 08:30:19

SAN DIEGO, June 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM), announced today that Cardium Therapeutics will announce interim results on the Generx(®) angiogenic gene therapy product candidate international ASPIRE Phase 3 registration study at the 2014 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), this year's global event for biotechnology will take place June 23-26 at the San Diego Convention Center...

2014-06-10 12:32:05

Internationally recognized physician-scientists joining fight against devastating childhood diseases as hospital expands clinical and basic science research MEMPHIS, Tenn., June 10, 2014 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital officials today announced the appointment of three internationally recognized physician-scientists to leadership positions. Mitchell Weiss, M.D., Ph.D., has been named chair of the St. Jude Department of Hematology. He was recruited...

2014-06-05 23:01:58

Barbara and Edward Netter awarded prestigious distinction by the American Society of Gene and Cell Therapy. Washington, DC (PRWEB) June 05, 2014 Barbara Netter and her late husband Edward Netter – Greenwich residents and founders of Alliance for Cancer Gene Therapy (ACGT) – were awarded the prestigious Distinguished Service Award by the American Society of Gene and Cell Therapy (ASGCT) on Thursday, May 22, 2014. The award – presented in Washington, DC before an audience of over...

2014-06-03 23:03:40

Eighth-annual Greenwich-Stamford Open Water Swim unites Connecticut residents in the fight against cancer. Stamford, CT (PRWEB) June 03, 2014 Across Connecticut, residents intent on conquering cancer are preparing to swim the Long Island Sound to raise funds, bolster awareness and seek out a cure at the eighth-annual Greenwich-Stamford Swim Across America (SAA) benefiting the Alliance for Cancer Gene Therapy (ACGT). On Saturday, June 21, hundreds of swimmers and philanthropists will unite...

2014-06-02 16:25:27

PHILADELPHIA, June 2, 2014 /PRNewswire/ -- Spark Therapeutics, Inc., a late-stage gene therapy company developing treatments for a wide range of rare, debilitating diseases, announced today that company leadership will present at three healthcare investor meetings in June. -- 2014 Jefferies Global Healthcare Conference, New York City, June 5 Jeffrey D. Marrazzo, co-founder and CEO of Spark, will present on Spark's leadership in the advancement of potentially curative,...


Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related